English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Krystal Biotech
+
Technology/Innovation
Pacient Daily
| May 22, 2023
Krystal Biotech Receives FDA Approval for the First-Ever Redosable Gene Therapy, VYJUVEK™ (beremagene geperpavec-svdt) for the Treatment of Dystrophic Epidermolysis Bullosa
+
Technology/Innovation
Patient Daily
| Apr 26, 2023
Krystal Biotech to Present at Association for Research in Vision and Ophthalmology Annual Meeting
+
Technology/Innovation
Patient Daily
| Apr 24, 2023
Krystal Biotech to Present at Association for Research in Vision and Ophthalmology Annual Meeting
+
Technology/Innovation
Patient Daily
| Apr 24, 2023
Jeune Aesthetics Announces Dosing of First Subject in Phase 1, Cohort 3 Study of KB301 for the Improvement of Lateral Canthal Lines at Rest
Trending
+
Pharmaceuticals
Patient Daily
| Aug 4, 2026
Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+
Pharmaceuticals
Patient Daily
| Aug 6, 2026
FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+
Regulatory
M. R. Armstrong
| Aug 4, 2026
Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+
Pharmaceuticals
Patient Daily
| Aug 5, 2026
Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes
